Peter Rossing

Peter Rossing

Clinical Professor

Member of:

  • Internal Medicine: Endocrinology

ORCID: 0000-0002-1531-4294

Publication year:
All
61 - 70 out of 507Page size: 10
  1. 2023
  2. Published

    Extrapolated longer-term effects of the DAPA-CKD trial: a modelling analysis

    McEwan, P., Boyce, R., Sanchez, J. J. G., Sjöström, C. D., Stefansson, B., Nolan, S., Correa-Rotter, R., Rossing, Peter, Chertow, G. M., McMurray, J. J. V., Wheeler, D. C. & Heerspink, H. J. L., 2023, In: Nephrology Dialysis Transplantation. 38, 5, p. 1260-1270 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Finerenone and effects on mortality in chronic kidney disease and type 2 diabetes: a FIDELITY analysis

    Filippatos, G., Anker, S. D., August, P., Coats, A. J. S., Januzzi, J. L., Mankovsky, B., Rossing, Peter, Ruilope, L. M., Pitt, B., Sarafidis, P., Teerlink, J. R., Kapelios, C. J., Gebel, M., Brinker, M., Joseph, A., Lage, A., Bakris, G. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 2, p. 183-191 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Finerenone efficacy in patients with chronic kidney disease, type 2 diabetes and atherosclerotic cardiovascular disease

    Filippatos, G., Anker, S. D., Pitt, B., McGuire, D. K., Rossing, Peter, Ruilope, L. M., Butler, J., Jankowska, E. A., Michos, E. D., Farmakis, D., Farjat, A. E., Kolkhof, P., Scalise, A., Joseph, A., Bakris, G. L. & Agarwal, R., 2023, In: European heart journal. Cardiovascular pharmacotherapy. 9, 1, p. 85-93 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Finerenone in Black Patients With Type 2 Diabetes and CKD: A Post hoc Analysis of the Pooled FIDELIO-DKD and FIGARO-DKD Trials

    Flack, J. M., Agarwal, R., Anker, S. D., Pitt, B., Ruilope, L. M., Rossing, Peter, Adler, S. G., Fried, L., Jamerson, K., Toto, R., Brinker, M., Farjat, A. E., Kolkhof, P., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 12, 11 p., 100730.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis

    Rosas, S. E., Ruilope, L. M., Anker, S. D., Pitt, B., Rossing, Peter, Bonfanti, A. A. C., Correa-Rotter, R., González, F., Munoz, C. F. J., Pergola, P., Umpierrez, G. E., Scalise, A., Scott, C., Lawatscheck, R., Joseph, A., Bakris, G. L. & FIDELIO-DKD and FIGARO-DKD Investigators, F. A. F. I., 2023, In: Kidney Medicine. 5, 10, 10 p., 100704.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Finerenone in patients across the spectrum of chronic kidney disease and type 2 diabetes by glucagon-like peptide-1 receptor agonist use

    the FIDELIO-DKD and FIGARO-DKD investigators, T. F. A. F. I., 2023, In: Diabetes, Obesity and Metabolism. 25, 2, p. 407-416 10 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Four missense genetic variants in CUBN are associated with higher levels of eGFR in non-diabetes but not in diabetes mellitus or its subtypes: A genetic association study in Europeans

    Uglebjerg, N., Ahmadizar, F., Aly, D. M., Cañadas-Garre, M., Hill, C., Naber, A., Oddsson, A., Singh, S. S., Smyth, L., Trégouët, D. A., Chaker, L., Ghanbari, M., Steinthorsdottir, V., Ahlqvist, E., Hadjadj, S., Van Hoek, M., Kavousi, M., McKnight, A. J., Sijbrands, E. J., Stefansson, K. & 3 others, Simons, M., Rossing, Peter & Ahluwalia, T. S., 2023, In: Frontiers in Endocrinology. 14, 11 p., 1081741.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Gene expression signature predicts rate of type 1 diabetes progression

    Suomi, T., Starskaia, I., Kalim, U. U., Rasool, O., Jaakkola, M. K., Grönroos, T., Välikangas, T., Brorsson, C., Mazzoni, G., Bruggraber, S., Overbergh, L., Dunger, D., Peakman, M., Chmura, P., Brunak, S., Schulte, A. M., Mathieu, C., Knip, M., Lahesmaa, R., Elo, L. L. & 4 others, Pociot, Flemming, Johannesen, Jesper, Rossing, Peter & INNODIA consortium, I. C., 2023, In: EBioMedicine. 92, 18 p., 104625.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Glucagon-like peptide-1 treatment reduces the risk of diabetes-type 2 related amputations: A cohort study in Denmark

    Schäfer, Z., Mathisen, A., Thomsen, T. R., Rossing, Peter & Kirketerp-Møller, K., 2023, In: Diabetes Research and Clinical Practice. 202, 7 p., 110799.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. Published

    HbA1c and beyond

    Rossing, Peter, 2023, In: Nephrology Dialysis Transplantation. 38, 1, p. 34-40 7 p.

    Research output: Contribution to journal › Review › Research › peer-review

Previous 1...3 4 5 6 7 8 9 10 ...51 Next

ID: 12937790